http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101232184-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14 |
filingDate | 2009-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101232184-B1 |
titleOfInvention | Vascular restenosis preventive agent containing 4-O-methyl-honokiol as an active ingredient |
abstract | The present invention relates to a vascular restenosis preventive agent comprising 4-O-methylhonokiol as an active ingredient and a pharmaceutically acceptable carrier, which can prevent vascular restenosis occurring after a stent procedure. The vascular restenosis preventive agent of the present invention may prevent vascular restenosis occurring after stent surgery without side effects, and thus may be widely used for the prevention and treatment of safer coronary artery disease.n n n n 4-O-methylhonokiol, stent, vascular restenosis |
priorityDate | 2009-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.